Online Only Articles

Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole;Toulouse III Paul Sabatier University;Inserm, UMR1037 Centre de Recherche en Cancerologie de Toulouse, laboratoire d’excellence TOUCAN
Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole
Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole
Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole
Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole
Department of Biostatistics, IUCT-Oncopole, CHU Toulouse
Regional Cancer Network Onco-occitanie, IUCT-Oncopole, Toulouse
Hospices Civils de Lyon, Claude Bernard Lyon 1 University, INSERM 1052, Pierre-Bénite
Institut de Pathologie, CHU Lille, Avenue Oscar Lambret
Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole;Toulouse III Paul Sabatier University;Inserm, UMR1037 Centre de Recherche en Cancerologie de Toulouse, laboratoire d’excellence TOUCAN
Pathology, CHU Bordeaux, Inserm U1053, France
Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole;Toulouse III Paul Sabatier University;Inserm, UMR1037 Centre de Recherche en Cancerologie de Toulouse, laboratoire d’excellence TOUCAN
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.198572